- Home
- CYH vs THW Comparison
CYH vs THW Comparison
Compare CYH & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CYH | THW |
|---|---|---|
| Founded | 1985 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.2M | 513.9M |
| IPO Year | 2000 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CYH | THW |
|---|---|---|
| Price | $2.97 | $11.86 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.57 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 112.4K |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 196.67 | N/A |
| EPS | ★ 3.77 | N/A |
| Revenue | ★ $12,485,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.17 | N/A |
| P/E Ratio | $0.78 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $9.80 |
| 52 Week High | $4.43 | $13.19 |
Technical Indicators
Market Signals| Indicator | CYH | THW |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 45.80 |
| Support Level | $2.94 | $11.83 |
| Resistance Level | $3.25 | $12.95 |
| Average True Range (ATR) | 0.12 | 0.25 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 35.11 | 50.74 |
Price Performance
Historical ComparisonAbout CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.